Developing evidence-based strategies to manage and treat bone and joint disease

Despite affecting one in eight adults, bone and joint disease research remains underfunded. Arthritis occurs four times more often than diabetes, however, diabetes receives more than double the amount of government (NHMRC) funding.

We conduct bone and joint research out of the Kolling Institute, and are developing evidence-based strategies to manage and treat these disorders through surgical and medical breakthroughs. Our team of medical researchers are leaders in their fields, actively involved in clinical and basic-science-discovery research that addresses issues that are relevant to patients and their clinicians to better understand the conditions and inform their treatment:  “a bedside-to-bench” approach.

Our research aims to:

  • identify the causes of joint destruction in arthritis
  • develop surgical and medical treatments which will restore joint structure and function
  • understand the pathophysiology of bone, cartilage and tendon failure in musculoskeletal disorders and devise new approaches for their repair and regeneration
  • identify the factors (inherited, occupational, hormonal, etc.) which contribute to the morbidity of bone and joint disease in the Australian community.

We are comprised of two clinical departments and three laboratory groups which carry out extensive research in the musculoskeletal field.

A number of our clinical trials are also open to members of the public to volunteer.